Arcutis Biotherapeutics, Inc. · NASDAQ:ARQT

Burnett Patrick sold 684 Arcutis Biotherapeutics, Inc. shares (Form 4)

Traded May 4, 2026 · Filed May 6, 2026

On May 4, 2026, Burnett Patrick (See Remarks) sold 684 Arcutis Biotherapeutics, Inc. shares at US$23.61 for US$16,149 under a trading plan, leaving 120,466 shares. Filed May 6, 2026 (Form 4).

Sold
684 shares
Price
US$23.61
Value
US$16,149
Holding after
120,466 shares
Trading plan
Yes (Made under a plan set in advance)
Role
See Remarks

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 4, 2026Common StockSale684US$23.61120,466Direct

Source

View original at SEC

Related